awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38887592-308F1333-0575-41AA-A90A-D020F6223EE6
Q38887592-308F1333-0575-41AA-A90A-D020F6223EE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38887592-308F1333-0575-41AA-A90A-D020F6223EE6
Inhibition of the HER2-YB1-AR axis with Lapatinib synergistically enhances Enzalutamide anti-tumor efficacy in castration resistant prostate cancer
P2860
Q38887592-308F1333-0575-41AA-A90A-D020F6223EE6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38887592-308F1333-0575-41AA-A90A-D020F6223EE6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1d3f03354de3b50ef3396078ddc2cd6b78408f94
P2860
Intermittent androgen suppression for prostate cancer: rationale and clinical experience.